OrganoClick appoints new COO

OrganoClick appoints new COO

OrganoClick has appointed Daniel Lund as new COO for the Group. He will head the Group operations

All News Press Releases

OrganoClick appoints new COO

OrganoClick has appointed Daniel Lund as new COO for the Group. He will head the Group operations with responsibility for purchasing, production and logistics. Daniel has more then 20 years of experience from production, quality assurance, and logistics from Astra Zeneca, Pfizer, Medivir and Bactiguard.

Daniel has a M. Sc. in Chemical Engineering from Luleå University of Technology. His most recent position has been the role as COO of Bactiguard, a medtech company which produces and supplies an antibacterial coating for various healthcare applications. Previous positions include Supply Chain Director for Pfizer Strängnäs, Supply Chain Director for Medivir and more then 14 years of leading positions within Astra Zeneca's production in Södertälje within both production planning, logistics and quality assurance.

"We are very happy to welcome Daniel to OrganoClick. Daniel has a broad experience from chemical production within both big corporations and smaller entrepreneurial companies which makes him a very good fit as our new COO. His experience from production management, planning, quality assurance and logistics will be very valuable in our future global expansion", says Mårten Hellberg, CEO of OrganoClick. 

"I am very happy for the trust and the challenge. I have a strong engagement for sustainability and the environment and I am happy that I now can use my experiences within production and chemistry in a business where sustainability is an integral part of the business idea. I'm now looking forward in being part of OganoClick's continuous journey in building a new Swedish industry based on green chemistry”, says Daniel Lund.

Daniel will start his position as COO and member of the management team 8 February 2020. At the same time, Mikael Wickström who currently holds the position as COO, will start his new position as Technical Director for OrganoClick.  

This disclosure contains information that OrganoClick AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 25-11-2020 10:00 CET.

.........................................................................................

For more information, please contact:

Mårten Hellberg, CEO

0707 - 16 48 90, marten.hellberg@organoclick.com

……………………………………………………………………………………………………………………………………………………………….

About OrganoClick

OrganoClick AB (publ) is a public Swedish cleantech company listed on Nasdaq First North Growth Market. The company develops, produces and markets functional materials based on environmentally friendly fiber chemistry. Examples of products that are marketed by OrganoClick are the durable water repellent technology for textiles OrganoTex®, the biocomposite material OrganoComp®, surface treatment and maintenance products for villa and property owners under the brand BIOkleen®, biobased binder under the trade name OC-BioBinder™ and the flame and rot-resistant timber OrganoWood® (through the joint-venture OrganoWood AB). OrganoClick was founded in 2006 as a commercial spin-off company based on research performed at Stockholm University and the Swedish University of Agricultural Sciences within environmentally friendly fiber chemistry. OrganoClick has won a number of prizes, such as "Sweden's Most Promising Start -up" and "Sweden's Best Environmental Innovation", and has also received a number of awards, such as the WWF "Climate Solver" award, listed as a SUSTAINIA100 company and has also appeared for two years on the Affärsvärldens and NyTekniks list of Sweden's top 33 hottest technology companies. OrganoClick has its head office, production and R&D located in Täby, north of Stockholm. OrganoClick's Certified Adviser on Nasdaq First North Growth Market is Mangold Fondkommission AB, tel: +46 (0)8 503 01 551, email: ca@mangold.se.